GLOBAL STEM CELL ASSAY MARKETFORECAST 2017-2025
KEY FINDINGS
The global market for stem cell assay is anticipated to upsurge at a CAGR of 21.79% during the forecast period of 2017-2025. Growing investment in the research activities is the key factor intensifying the growth of the stem cell assay. Stem cells are extensively investigated owing to its regenerative potentials. The increasing adoption of stem cell assay for drug screening & testing is one of the major reasons driving the industry research market.
MARKET INSIGHTS
The global stem cell assay market is segmented on the basis of types of assay, product, kits, application, end-user and geography. The global stem cell assay market by type is segmented into cell viability and toxicity assays, isolation and purification assays, cell identification assays, cell differentiation assays, cell function assays and cell apoptosis assays. The product of global stem cell assay is segmented into instruments and detection kits. The kits of stem cell assay market are further segmented into adult stem cell kits, human embryonic stem cell kit. The stem cell market by application is further bifurcated into regenerative medicine and therapy development, drug discovery and development and clinical research market. The end-user of stem cell market is segmented into research institutes and industry research. The stem cell assay market by geography is segmented into North America, Europe, Asia-Pacific and rest of the world. Increased Adoption of Stem Cell Assay, augmenting Technology, expense in Stem Cell Research are the major drivers for the market growth. The rising adoption of stem cell assay for drug screening& testing is one of the major reasons driving the industry research market.
REGIONAL INSIGHTS
North America held the colossal markets share of 37.4% in 2016 in global stem cell market. The growth in the North America stem cell assay market is mainly driven by the growing prevalence of chronic diseases such as cancer, cardiovascular diseases, and rise in the research and development spending in the biotechnology sector. APAC region is anticipated to grow at a faster rate. The growing prevalence of the chronic diseases such as cancer, cardiovascular disorders etc. have become the key growth driver of the Asia Pacific stem cell assay market. The rising prevalence of chronic disorders and an increase in the patient pool in India and moreover the growing biotechnology industry in the country is increasing the growth in the India stem cell assay market. The Europe stem cell assay market is mainly driven by the rising prevalence of chronic disorders such as cancer and cardiovascular disorders. Moreover, the rising healthcare spending is also boosting the growth in the Europe stem cell assay market.
COMPETITIVE INSIGHTS
Major players in the Stem cell assay markets are Promega Corporation, cell bio labs, Inc., GE healthcare, Thermo fisher scientific Pvt Ltd, Merck Millipore (holding company is Merck K GAA), Hemogenix Inc., Stem cell technologies, Bio-rad, R &D systems, Cellular dynamics international (holding company Fujifilm).
The global market for stem cell assay is anticipated to upsurge at a CAGR of 21.79% during the forecast period of 2017-2025. Growing investment in the research activities is the key factor intensifying the growth of the stem cell assay. Stem cells are extensively investigated owing to its regenerative potentials. The increasing adoption of stem cell assay for drug screening & testing is one of the major reasons driving the industry research market.
MARKET INSIGHTS
The global stem cell assay market is segmented on the basis of types of assay, product, kits, application, end-user and geography. The global stem cell assay market by type is segmented into cell viability and toxicity assays, isolation and purification assays, cell identification assays, cell differentiation assays, cell function assays and cell apoptosis assays. The product of global stem cell assay is segmented into instruments and detection kits. The kits of stem cell assay market are further segmented into adult stem cell kits, human embryonic stem cell kit. The stem cell market by application is further bifurcated into regenerative medicine and therapy development, drug discovery and development and clinical research market. The end-user of stem cell market is segmented into research institutes and industry research. The stem cell assay market by geography is segmented into North America, Europe, Asia-Pacific and rest of the world. Increased Adoption of Stem Cell Assay, augmenting Technology, expense in Stem Cell Research are the major drivers for the market growth. The rising adoption of stem cell assay for drug screening& testing is one of the major reasons driving the industry research market.
REGIONAL INSIGHTS
North America held the colossal markets share of 37.4% in 2016 in global stem cell market. The growth in the North America stem cell assay market is mainly driven by the growing prevalence of chronic diseases such as cancer, cardiovascular diseases, and rise in the research and development spending in the biotechnology sector. APAC region is anticipated to grow at a faster rate. The growing prevalence of the chronic diseases such as cancer, cardiovascular disorders etc. have become the key growth driver of the Asia Pacific stem cell assay market. The rising prevalence of chronic disorders and an increase in the patient pool in India and moreover the growing biotechnology industry in the country is increasing the growth in the India stem cell assay market. The Europe stem cell assay market is mainly driven by the rising prevalence of chronic disorders such as cancer and cardiovascular disorders. Moreover, the rising healthcare spending is also boosting the growth in the Europe stem cell assay market.
COMPETITIVE INSIGHTS
Major players in the Stem cell assay markets are Promega Corporation, cell bio labs, Inc., GE healthcare, Thermo fisher scientific Pvt Ltd, Merck Millipore (holding company is Merck K GAA), Hemogenix Inc., Stem cell technologies, Bio-rad, R &D systems, Cellular dynamics international (holding company Fujifilm).
1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
2.5. ESTIMATION METHODOLOGY
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. ASIA PACIFIC IS THE FASTEST GROWING STEM CELL ASSAY MARKET
3.2.2. INDUSTRY RESEARCH IS THE LEADING END-USER SEGMENT
3.2.3. DEMAND FOR REGENERATIVE MEDICINE
4. MARKET OVERVIEW
4.1. MARKET DRIVERS
4.1.1. RISING ADOPTION OF STEM CELL ASSAY
4.1.2. IMPROVEMENT IN TECHNOLOGY
4.1.3. SPENDING IN STEM CELL RESEARCH
4.2. MARKET RESTRAINTS
4.2.1. HIGH COST FOR TREATMENT
4.2.2. SLOW RESPONSE TIME OF REGULATORY BODIES
4.3. MARKET OPPORTUNITIES
4.3.1. CHANGING MARKET DYNAMICS
4.4. MARKET CHALLENGES
4.4.1. ISSUE IN THE PATIENT’S IMMUNE SYSTEM
5. MARKET SEGMENTATION
5.1. BY TYPES OF ASSAY
5.1.1. CELL VIABILITY & TOXICITY ASSAYS
5.1.2. ISOLATION/PURIFICATION ASSAYS
5.1.3. CELL IDENTIFICATION ASSAYS
5.1.4. CELL DIFFERENTIATION ASSAYS
5.1.5. CELL FUNCTION ASSAYS
5.1.6. CELL APOPTOSIS ASSAYS
5.2. BY PRODUCT
5.2.1. INSTRUMENTS
5.2.2. DETECTION KITS
5.3. BY KITS
5.3.1. ADULT STEM CELL KITS
5.3.1.1. MESENCHYMAL STEM CELL KITS
5.3.1.2. INDUCED PLURIPOTENT STEM CELL KITS
5.3.1.3. HEMATOPOIETIC STEM CELL KITS
5.3.1.4. NEURONAL STEM CELLS KITS
5.3.1.5. UMBILICAL CORD STEM CELLS
5.3.2. HUMAN EMBRYONIC STEM CELLS KITS
5.4. BY APPLICATION
5.4.1. REGENERATIVE MEDICINE & THERAPY DEVELOPMENT
5.4.1.1. ORTHOPEDIC & MUSCULOSKELETAL SPINE STEM CELL ASSAY)
5.4.1.2. DERMATOLOGY STEM CELL
5.4.1.3. CARDIOVASCULAR STEM CELL ASSAY
5.4.1.4. CENTRAL NERVOUS SYSTEM STEM CELL ASSAY
5.4.1.5. ONCOLOGY STEM CELL ASSAY
5.4.2. DRUG DISCOVERY AND DEVELOPMENT
5.4.3. CLINICAL RESEARCH MARKET
5.5. END USER
5.5.1. RESEARCH INSTITUTES
5.5.2. INDUSTRY RESEARCH
6. KEY ANALYTICAL
6.1. PORTER’S FIVE FORCE MODEL
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
6.1.3. BARGAINING POWER OF BUYER
6.1.4. BARGAINING POWER OF SUPPLIER
6.1.5. INTENSITY OF COMPETITIVE RIVALRY
6.2. PESTEL ANALYSIS
6.3. OPPORTUNITY MATRIX
6.4. KEY BUYING CRITERIA
6.4.1. PRICING
6.4.2. EFFICACY
6.4.3. ACCURACY
6.5. STRATEGIC RECOMMENDATION & CONCLUSION
6.6. VENDOR LANDSCAPE
6.7. VALUE CHAIN ANALYSIS
7. REGIONAL ANALYSIS
7.1. NORTH AMERICA STEM CELL ASSAY MARKET
7.1.1. UNITED STATES STEM CELL ASSAY MARKET
7.1.2. CANADA STEM CELL ASSAY MARKET
7.2. EUROPE STEM CELL ASSAY MARKET
7.2.1. UNITED KINGDOM STEM CELL ASSAY MARKET
7.2.2. FRANCE STEM CELL ASSAY MARKET
7.2.3. GERMANY STEM CELL ASSAY MARKET
7.2.4. SPAIN STEM CELL ASSAY MARKET
7.2.5. ITALY STEM CELL ASSAY MARKET
7.2.6. ROE STEM CELL ASSAY MARKET
7.3. ASIA PACIFIC STEM CELL ASSAY MARKET
7.3.1. INDIA STEM CELL ASSAY MARKET
7.3.2. CHINA STEM CELL ASSAY MARKET
7.3.3. JAPAN STEM CELL ASSAY MARKET
7.3.4. SOUTH KOREA STEM CELL ASSAY MARKET
7.3.5. ROAPAC STEM CELL ASSAY MARKET
7.4. REST OF THE WORLD STEM CELL ASSAY MARKET
7.4.1. LATIN AMERICA STEM CELL ASSAY MARKET
7.4.2. MENA STEM CELL ASSAY MARKET
7.4.3. AFRICA STEM CELL ASSAY MARKET
8. COMPANY PROFILES
8.1. PROMEGA CORPORATION
8.1.1. OVERVIEW
8.1.2. PRODUCTS PORTFOLIO
8.1.3. STRATEGIC INITIATIVES
8.1.4. SCOT ANALYSIS
8.1.5. STRATEGIC ANALYSIS
8.2. CELL BIO LABS, INC.
8.2.1. OVERVIEW
8.2.2. PRODUCT PORTFOLIO
8.2.3. SCOT ANALYSIS
8.2.4. STRATEGIC ANALYSIS
8.3. GE HEALTHCARE
8.3.1. OVERVIEW
8.3.2. PRODUCT PORTFOLIO
8.3.3. SCOT ANALYSIS
8.3.4. STRATEGIC ANALYSIS
8.4. THERMO FISHER SCIENTIFIC PVT. LTD
8.4.1. OVERVIEW
8.4.2. PRODUCT PORTFOLIO
8.4.3. STRATEGIC INITIATIVE
8.4.4. SCOT ANALYSIS
8.4.5. STRATEGIC ANALYSIS
8.5. MERCK MILLIPORE (HOLDING COMPANY IS MERCKKGAA)
8.5.1. OVERVIEW
8.5.2. PRODUCT PORTFOLIO
8.5.3. STRATEGIC INITIATIVES
8.5.4. SCOT ANALYSIS
8.5.5. STRATEGIC ANALYSIS
8.6. HEMOGENIX INC.
8.6.1. OVERVIEW
8.6.2. PRODUCT PORTFOLIO
8.6.3. SCOT ANALYSIS
8.6.4. STRATEGIC ANALYSIS
8.7. STEMCELL TECHNOLOGIES
8.7.1. OVERVIEW
8.7.2. PRODUCT PORTFOLIO
8.7.3. SCOT ANALYSIS
8.7.4. STRATEGIC ANALYSIS
8.8. BIO-RAD
8.8.1. OVERVIEW
8.8.2. PRODUCT PORTFOLIO
8.8.3. SCOT ANALYSIS
8.8.4. STRATEGIC ANALYSIS
8.9. R&D SYSTEMS
8.9.1. OVERVIEW
8.9.2. PRODUCT PORTFOLIO
8.9.3. SCOT ANALYSIS
8.9.4. STRATEGIC ANALYSIS
8.10. CELLULAR DYNAMICS INTERNATIONAL (HOLDING COMPANY FUJIFILM)
8.10.1. OVERVIEW
8.10.2. PRODUCT PORTFOLIO
8.10.3. STRATEGIC INITIATIVES
8.10.4. SCOT ANALYSIS
8.10.5. STRATEGIC ANALYSIS
TABLE LIST
TABLE 1 GLOBAL STEM CELL ASSAY MARKET BY REGION, 2017-2025 ($ MILLION)
TABLE 2 GLOBAL STEM CELL ASSAY MARKET BY TYPES OF ASSAY 2017-2025 ($ MILLION)
TABLE 3 GLOBAL STEM CELL ASSAY MARKET BY CELL VIABILITY & TOXICITY ASSAYS BY REGION 2017-2025 ($ MILLION)
TABLE 4 GLOBAL STEM CELL ASSAY MARKET BY ISOLATION/PURIFICATION ASSAYS BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 5 GLOBAL STEM CELL ASSAY MARKET BY CELL IDENTIFICATION ASSAYS BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 6 GLOBAL STEM CELL ASSAY MARKET IN CELL DIFFERENTIATION ASSAYS BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 7 GLOBAL STEM CELL ASSAY MARKET IN CELL FUNCTION ASSAYS BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 8 GLOBAL STEM CELL ASSAY MARKET BY CELL APOPTOSIS ASSAYS BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 9 GLOBAL STEM CELL ASSAY MARKET BY PRODUCT 2017-2025 ($ MILLION)
TABLE 10 GLOBAL STEM CELL ASSAY MARKET BY INSTRUMENTS MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 11 GLOBAL STEM CELL ASSAY MARKET BY DETECTION KITS MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 12 GLOBAL STEM CELL ASSAY MARKET BY KITS 2017-2025 ($ MILLION)
TABLE 13 GLOBAL STEM CELL ASSAY MARKET BY ADULT STEM CELL KITS 2017-2025 ($ MILLION)
TABLE 14 GLOBAL STEM CELL ASSAY MARKET BY ADULT STEM CELL KITS BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 15 GLOBAL HUMAN EMBRYONIC STEM CELLS KITS MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 16 GLOBAL STEM CELL ASSAY MARKET BY APPLICATION 2017-2025 ($ MILLION)
TABLE 17 GLOBAL REGENERATIVE MEDICINE MARKET BY DIFFERENT CELL THERAPIES 2017-2025 ($ MILLION)
TABLE 18 GLOBAL REGENERATIVE AND MEDICINE THERAPY MARKET BY REGION 2017-2025 ($ MILLION)
TABLE 19 GLOBAL STEM CELL ASSAY DRUG DISCOVERY APPLICATION MARKET BY REGION 2017-2025 ($ MILLION)
TABLE 20 GLOBAL STEM CELL ASSAY CLINICAL RESEARCH MARKET BY REGION 2017-2025 ($ MILLION)
TABLE 21 GLOBAL STEM CELL ASSAY MARKET BY END USER 2017-2025($ MILLION)
TABLE 22 GLOBAL STEM CELL ASSAY MARKET BY RESEARCH INSTITUTES BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 23 RESEARCH ACTIVITIES ON DIFFERENT TYPE OF STEM CELLS
TABLE 24 GLOBAL STEM CELL ASSAY MARKET BY INDUSTRY RESEARCH BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 25 NORTH AMERICA STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
TABLE 26 RESEARCH AND DEVELOPMENT FUNDING IN 2016
TABLE 27 EUROPE STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
TABLE 28 CARDIOVASCULAR DISORDERS IN UK IN 2015
TABLE 29 ASIA PACIFIC STEM CELL ASSAY MARKET BY COUNTRIES 2014-2022 ($ MILLION)
TABLE 30 REST OF THE WORLD STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURES LIST
FIGURE 1 GLOBAL TREND OF STEM CELL ASSAY MARKET
FIGURE 2 MARKET REVENUE OF INDUSTRY RESEARCH IN STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 3 REGENERATIVE MEDICINE & THERAPY DEVELOPMENT BY MARKET SHARE 2016 & 2025 (%)
FIGURE 4 INVESTMENT BY THE PHARMACY MEMBERS IN RESEARCH AND DEVELOPMENT ($ BILLION)
FIGURE 5 INVESTMENT ON STEM CELL RESEARCH BY NIH 2013-2016 ($ BILLION)
FIGURE 6 GLOBAL STEM CELL ASSAY MARKET BY MESENCHYMAL STEM CELLS KITS 2017-2025 ($ MILLION)
FIGURE 7 GLOBAL STEM CELL ASSAY MARKET BY PLURIPOTENT STEM CELLS KITS 2017-2025 ($ MILLION)
FIGURE 8 GLOBAL STEM CELL ASSAY MARKET BY HEMATOPOIETIC STEM CELLS 2017-2025 ($ MILLION)
FIGURE 9 GLOBAL STEM CELL ASSAY MARKET BY NEURONAL STEM CELLS 2017-2025 ($ MILLION)
FIGURE 10 GLOBAL STEM CELL ASSAY MARKET BY UMBILICAL CORD BLOOD CELLS 2017-2025 ($ MILLION)
FIGURE 11 GLOBAL STEM CELL ASSAY MARKET BY HUMAN EMBRYONIC STEM CELLS 2017-2025 ($ MILLION)
FIGURE 12 GLOBAL REGENERATIVE MEDICINE MARKET BY SECTOR 2016 & 2025 (%)
FIGURE 13 GLOBAL STEM CELL ASSAY APPLICATION MARKET BY REGENERATIVE MEDICINE AND THERAPY 2017-2025 ($ MILLION)
FIGURE 14 GLOBAL STEM CELL ASSAY APPLICATION MARKET BY ORTHOPEDIC & MUSCULOSKELETAL SPINE STEM CELL ASSAY 2017-2025 ($ MILLION)
FIGURE 15 GLOBAL STEM CELL ASSAY APPLICATION MARKET BY DERMATOLOGY STEM CELL 2017-2025 ($ MILLION)
FIGURE 16 GLOBAL STEM CELL ASSAY APPLICATION MARKET BY CARDIOVASCULAR STEM CELL 2017-2025 ($ MILLION)
FIGURE 17 GLOBAL STEM CELL ASSAY APPLICATION MARKET BY CENTRAL NERVOUS SYSTEM STEM CELL ASSAY 2014- 2023 ($ MILLION)
FIGURE 18 GLOBAL STEM CELL ASSAY APPLICATION MARKET BY ONCOLOGY ASSAY 2017-2025 ($ MILLION)
FIGURE 19 GLOBAL STEM CELL ASSAY APPLICATION MARKET BY DRUG DISCOVERY AND DEVELOPMENT 2017-2025 ($ MILLION)
FIGURE 20 GLOBAL STEM CELL ASSAY APPLICATION MARKET BY CLINICAL RESEARCH 2017-2025 ($ MILLION)
FIGURE 21 GLOBAL STEM CELL ASSAY MARKET BY RESEARCH INSTITUTES 2017-2025 ($ MILLION)
FIGURE 22 GLOBAL STEM CELL ASSAY MARKET BY INDUSTRY RESEARCH 2017-2025 ($ MILLION)
FIGURE 23 TYPE OF CELL THERAPY IN THE YEAR 2015
FIGURE 24 INCREASING PREVALENCE OF CANCER ACROSS THE US IN 2016
FIGURE 25 NORTH AMERICA STEM CELL ASSAY REGIONAL MARKET BREAKDOWN 2016 & 2025 (%)
FIGURE 26 UNITED STATES (U.S.) STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 27 PREVALENCE OF THE CANCER DISORDERS AMONG THE CANADIAN POPULATION IN 2015
FIGURE 28 CANADA STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 29 EUROPE STEM CELL ASSAY MARKET REGIONAL OUTLOOK 2016 & 2025 (IN %)
FIGURE 30 UNITED KINGDOM (UK) STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 31 FRANCE STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 32 RISING AGING POPULATION IN GERMANY IN 2015
FIGURE 33 PREVALENCE OF AGING POPULATION ABOVE 65 YEARS 2005 & 2015 (%)
FIGURE 34 GERMANY STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 35 SPAIN STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 36 ITALY STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 37 ROE STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 38 GROWING PREVALENCE OF THE CHRONIC DISORDERS IN ASIAN COUNTRIES BY GENDER 2015
FIGURE 39 ASIA-PACIFIC MARKET SHARE BY REGION 206 & 2025 (%)
FIGURE 40 INDIA STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 41 CHINA STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 42 JAPAN STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 43 THE GROWING NUMBER OF BIOTECHNOLOGY FIRMS IN KOREA
FIGURE 44 SOUTH KOREA STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 45 ROAPAC STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 46 REST OF THE WORLD STEM CELL ASSAY MARKET BY COUNTRY 2016 & 2024 (%)
FIGURE 47 LATIN AMERICA STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 48 MENA STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 49 AFRICA STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
2.5. ESTIMATION METHODOLOGY
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. ASIA PACIFIC IS THE FASTEST GROWING STEM CELL ASSAY MARKET
3.2.2. INDUSTRY RESEARCH IS THE LEADING END-USER SEGMENT
3.2.3. DEMAND FOR REGENERATIVE MEDICINE
4. MARKET OVERVIEW
4.1. MARKET DRIVERS
4.1.1. RISING ADOPTION OF STEM CELL ASSAY
4.1.2. IMPROVEMENT IN TECHNOLOGY
4.1.3. SPENDING IN STEM CELL RESEARCH
4.2. MARKET RESTRAINTS
4.2.1. HIGH COST FOR TREATMENT
4.2.2. SLOW RESPONSE TIME OF REGULATORY BODIES
4.3. MARKET OPPORTUNITIES
4.3.1. CHANGING MARKET DYNAMICS
4.4. MARKET CHALLENGES
4.4.1. ISSUE IN THE PATIENT’S IMMUNE SYSTEM
5. MARKET SEGMENTATION
5.1. BY TYPES OF ASSAY
5.1.1. CELL VIABILITY & TOXICITY ASSAYS
5.1.2. ISOLATION/PURIFICATION ASSAYS
5.1.3. CELL IDENTIFICATION ASSAYS
5.1.4. CELL DIFFERENTIATION ASSAYS
5.1.5. CELL FUNCTION ASSAYS
5.1.6. CELL APOPTOSIS ASSAYS
5.2. BY PRODUCT
5.2.1. INSTRUMENTS
5.2.2. DETECTION KITS
5.3. BY KITS
5.3.1. ADULT STEM CELL KITS
5.3.1.1. MESENCHYMAL STEM CELL KITS
5.3.1.2. INDUCED PLURIPOTENT STEM CELL KITS
5.3.1.3. HEMATOPOIETIC STEM CELL KITS
5.3.1.4. NEURONAL STEM CELLS KITS
5.3.1.5. UMBILICAL CORD STEM CELLS
5.3.2. HUMAN EMBRYONIC STEM CELLS KITS
5.4. BY APPLICATION
5.4.1. REGENERATIVE MEDICINE & THERAPY DEVELOPMENT
5.4.1.1. ORTHOPEDIC & MUSCULOSKELETAL SPINE STEM CELL ASSAY)
5.4.1.2. DERMATOLOGY STEM CELL
5.4.1.3. CARDIOVASCULAR STEM CELL ASSAY
5.4.1.4. CENTRAL NERVOUS SYSTEM STEM CELL ASSAY
5.4.1.5. ONCOLOGY STEM CELL ASSAY
5.4.2. DRUG DISCOVERY AND DEVELOPMENT
5.4.3. CLINICAL RESEARCH MARKET
5.5. END USER
5.5.1. RESEARCH INSTITUTES
5.5.2. INDUSTRY RESEARCH
6. KEY ANALYTICAL
6.1. PORTER’S FIVE FORCE MODEL
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
6.1.3. BARGAINING POWER OF BUYER
6.1.4. BARGAINING POWER OF SUPPLIER
6.1.5. INTENSITY OF COMPETITIVE RIVALRY
6.2. PESTEL ANALYSIS
6.3. OPPORTUNITY MATRIX
6.4. KEY BUYING CRITERIA
6.4.1. PRICING
6.4.2. EFFICACY
6.4.3. ACCURACY
6.5. STRATEGIC RECOMMENDATION & CONCLUSION
6.6. VENDOR LANDSCAPE
6.7. VALUE CHAIN ANALYSIS
7. REGIONAL ANALYSIS
7.1. NORTH AMERICA STEM CELL ASSAY MARKET
7.1.1. UNITED STATES STEM CELL ASSAY MARKET
7.1.2. CANADA STEM CELL ASSAY MARKET
7.2. EUROPE STEM CELL ASSAY MARKET
7.2.1. UNITED KINGDOM STEM CELL ASSAY MARKET
7.2.2. FRANCE STEM CELL ASSAY MARKET
7.2.3. GERMANY STEM CELL ASSAY MARKET
7.2.4. SPAIN STEM CELL ASSAY MARKET
7.2.5. ITALY STEM CELL ASSAY MARKET
7.2.6. ROE STEM CELL ASSAY MARKET
7.3. ASIA PACIFIC STEM CELL ASSAY MARKET
7.3.1. INDIA STEM CELL ASSAY MARKET
7.3.2. CHINA STEM CELL ASSAY MARKET
7.3.3. JAPAN STEM CELL ASSAY MARKET
7.3.4. SOUTH KOREA STEM CELL ASSAY MARKET
7.3.5. ROAPAC STEM CELL ASSAY MARKET
7.4. REST OF THE WORLD STEM CELL ASSAY MARKET
7.4.1. LATIN AMERICA STEM CELL ASSAY MARKET
7.4.2. MENA STEM CELL ASSAY MARKET
7.4.3. AFRICA STEM CELL ASSAY MARKET
8. COMPANY PROFILES
8.1. PROMEGA CORPORATION
8.1.1. OVERVIEW
8.1.2. PRODUCTS PORTFOLIO
8.1.3. STRATEGIC INITIATIVES
8.1.4. SCOT ANALYSIS
8.1.5. STRATEGIC ANALYSIS
8.2. CELL BIO LABS, INC.
8.2.1. OVERVIEW
8.2.2. PRODUCT PORTFOLIO
8.2.3. SCOT ANALYSIS
8.2.4. STRATEGIC ANALYSIS
8.3. GE HEALTHCARE
8.3.1. OVERVIEW
8.3.2. PRODUCT PORTFOLIO
8.3.3. SCOT ANALYSIS
8.3.4. STRATEGIC ANALYSIS
8.4. THERMO FISHER SCIENTIFIC PVT. LTD
8.4.1. OVERVIEW
8.4.2. PRODUCT PORTFOLIO
8.4.3. STRATEGIC INITIATIVE
8.4.4. SCOT ANALYSIS
8.4.5. STRATEGIC ANALYSIS
8.5. MERCK MILLIPORE (HOLDING COMPANY IS MERCKKGAA)
8.5.1. OVERVIEW
8.5.2. PRODUCT PORTFOLIO
8.5.3. STRATEGIC INITIATIVES
8.5.4. SCOT ANALYSIS
8.5.5. STRATEGIC ANALYSIS
8.6. HEMOGENIX INC.
8.6.1. OVERVIEW
8.6.2. PRODUCT PORTFOLIO
8.6.3. SCOT ANALYSIS
8.6.4. STRATEGIC ANALYSIS
8.7. STEMCELL TECHNOLOGIES
8.7.1. OVERVIEW
8.7.2. PRODUCT PORTFOLIO
8.7.3. SCOT ANALYSIS
8.7.4. STRATEGIC ANALYSIS
8.8. BIO-RAD
8.8.1. OVERVIEW
8.8.2. PRODUCT PORTFOLIO
8.8.3. SCOT ANALYSIS
8.8.4. STRATEGIC ANALYSIS
8.9. R&D SYSTEMS
8.9.1. OVERVIEW
8.9.2. PRODUCT PORTFOLIO
8.9.3. SCOT ANALYSIS
8.9.4. STRATEGIC ANALYSIS
8.10. CELLULAR DYNAMICS INTERNATIONAL (HOLDING COMPANY FUJIFILM)
8.10.1. OVERVIEW
8.10.2. PRODUCT PORTFOLIO
8.10.3. STRATEGIC INITIATIVES
8.10.4. SCOT ANALYSIS
8.10.5. STRATEGIC ANALYSIS
TABLE LIST
TABLE 1 GLOBAL STEM CELL ASSAY MARKET BY REGION, 2017-2025 ($ MILLION)
TABLE 2 GLOBAL STEM CELL ASSAY MARKET BY TYPES OF ASSAY 2017-2025 ($ MILLION)
TABLE 3 GLOBAL STEM CELL ASSAY MARKET BY CELL VIABILITY & TOXICITY ASSAYS BY REGION 2017-2025 ($ MILLION)
TABLE 4 GLOBAL STEM CELL ASSAY MARKET BY ISOLATION/PURIFICATION ASSAYS BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 5 GLOBAL STEM CELL ASSAY MARKET BY CELL IDENTIFICATION ASSAYS BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 6 GLOBAL STEM CELL ASSAY MARKET IN CELL DIFFERENTIATION ASSAYS BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 7 GLOBAL STEM CELL ASSAY MARKET IN CELL FUNCTION ASSAYS BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 8 GLOBAL STEM CELL ASSAY MARKET BY CELL APOPTOSIS ASSAYS BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 9 GLOBAL STEM CELL ASSAY MARKET BY PRODUCT 2017-2025 ($ MILLION)
TABLE 10 GLOBAL STEM CELL ASSAY MARKET BY INSTRUMENTS MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 11 GLOBAL STEM CELL ASSAY MARKET BY DETECTION KITS MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 12 GLOBAL STEM CELL ASSAY MARKET BY KITS 2017-2025 ($ MILLION)
TABLE 13 GLOBAL STEM CELL ASSAY MARKET BY ADULT STEM CELL KITS 2017-2025 ($ MILLION)
TABLE 14 GLOBAL STEM CELL ASSAY MARKET BY ADULT STEM CELL KITS BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 15 GLOBAL HUMAN EMBRYONIC STEM CELLS KITS MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 16 GLOBAL STEM CELL ASSAY MARKET BY APPLICATION 2017-2025 ($ MILLION)
TABLE 17 GLOBAL REGENERATIVE MEDICINE MARKET BY DIFFERENT CELL THERAPIES 2017-2025 ($ MILLION)
TABLE 18 GLOBAL REGENERATIVE AND MEDICINE THERAPY MARKET BY REGION 2017-2025 ($ MILLION)
TABLE 19 GLOBAL STEM CELL ASSAY DRUG DISCOVERY APPLICATION MARKET BY REGION 2017-2025 ($ MILLION)
TABLE 20 GLOBAL STEM CELL ASSAY CLINICAL RESEARCH MARKET BY REGION 2017-2025 ($ MILLION)
TABLE 21 GLOBAL STEM CELL ASSAY MARKET BY END USER 2017-2025($ MILLION)
TABLE 22 GLOBAL STEM CELL ASSAY MARKET BY RESEARCH INSTITUTES BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 23 RESEARCH ACTIVITIES ON DIFFERENT TYPE OF STEM CELLS
TABLE 24 GLOBAL STEM CELL ASSAY MARKET BY INDUSTRY RESEARCH BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 25 NORTH AMERICA STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
TABLE 26 RESEARCH AND DEVELOPMENT FUNDING IN 2016
TABLE 27 EUROPE STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
TABLE 28 CARDIOVASCULAR DISORDERS IN UK IN 2015
TABLE 29 ASIA PACIFIC STEM CELL ASSAY MARKET BY COUNTRIES 2014-2022 ($ MILLION)
TABLE 30 REST OF THE WORLD STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURES LIST
FIGURE 1 GLOBAL TREND OF STEM CELL ASSAY MARKET
FIGURE 2 MARKET REVENUE OF INDUSTRY RESEARCH IN STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 3 REGENERATIVE MEDICINE & THERAPY DEVELOPMENT BY MARKET SHARE 2016 & 2025 (%)
FIGURE 4 INVESTMENT BY THE PHARMACY MEMBERS IN RESEARCH AND DEVELOPMENT ($ BILLION)
FIGURE 5 INVESTMENT ON STEM CELL RESEARCH BY NIH 2013-2016 ($ BILLION)
FIGURE 6 GLOBAL STEM CELL ASSAY MARKET BY MESENCHYMAL STEM CELLS KITS 2017-2025 ($ MILLION)
FIGURE 7 GLOBAL STEM CELL ASSAY MARKET BY PLURIPOTENT STEM CELLS KITS 2017-2025 ($ MILLION)
FIGURE 8 GLOBAL STEM CELL ASSAY MARKET BY HEMATOPOIETIC STEM CELLS 2017-2025 ($ MILLION)
FIGURE 9 GLOBAL STEM CELL ASSAY MARKET BY NEURONAL STEM CELLS 2017-2025 ($ MILLION)
FIGURE 10 GLOBAL STEM CELL ASSAY MARKET BY UMBILICAL CORD BLOOD CELLS 2017-2025 ($ MILLION)
FIGURE 11 GLOBAL STEM CELL ASSAY MARKET BY HUMAN EMBRYONIC STEM CELLS 2017-2025 ($ MILLION)
FIGURE 12 GLOBAL REGENERATIVE MEDICINE MARKET BY SECTOR 2016 & 2025 (%)
FIGURE 13 GLOBAL STEM CELL ASSAY APPLICATION MARKET BY REGENERATIVE MEDICINE AND THERAPY 2017-2025 ($ MILLION)
FIGURE 14 GLOBAL STEM CELL ASSAY APPLICATION MARKET BY ORTHOPEDIC & MUSCULOSKELETAL SPINE STEM CELL ASSAY 2017-2025 ($ MILLION)
FIGURE 15 GLOBAL STEM CELL ASSAY APPLICATION MARKET BY DERMATOLOGY STEM CELL 2017-2025 ($ MILLION)
FIGURE 16 GLOBAL STEM CELL ASSAY APPLICATION MARKET BY CARDIOVASCULAR STEM CELL 2017-2025 ($ MILLION)
FIGURE 17 GLOBAL STEM CELL ASSAY APPLICATION MARKET BY CENTRAL NERVOUS SYSTEM STEM CELL ASSAY 2014- 2023 ($ MILLION)
FIGURE 18 GLOBAL STEM CELL ASSAY APPLICATION MARKET BY ONCOLOGY ASSAY 2017-2025 ($ MILLION)
FIGURE 19 GLOBAL STEM CELL ASSAY APPLICATION MARKET BY DRUG DISCOVERY AND DEVELOPMENT 2017-2025 ($ MILLION)
FIGURE 20 GLOBAL STEM CELL ASSAY APPLICATION MARKET BY CLINICAL RESEARCH 2017-2025 ($ MILLION)
FIGURE 21 GLOBAL STEM CELL ASSAY MARKET BY RESEARCH INSTITUTES 2017-2025 ($ MILLION)
FIGURE 22 GLOBAL STEM CELL ASSAY MARKET BY INDUSTRY RESEARCH 2017-2025 ($ MILLION)
FIGURE 23 TYPE OF CELL THERAPY IN THE YEAR 2015
FIGURE 24 INCREASING PREVALENCE OF CANCER ACROSS THE US IN 2016
FIGURE 25 NORTH AMERICA STEM CELL ASSAY REGIONAL MARKET BREAKDOWN 2016 & 2025 (%)
FIGURE 26 UNITED STATES (U.S.) STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 27 PREVALENCE OF THE CANCER DISORDERS AMONG THE CANADIAN POPULATION IN 2015
FIGURE 28 CANADA STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 29 EUROPE STEM CELL ASSAY MARKET REGIONAL OUTLOOK 2016 & 2025 (IN %)
FIGURE 30 UNITED KINGDOM (UK) STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 31 FRANCE STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 32 RISING AGING POPULATION IN GERMANY IN 2015
FIGURE 33 PREVALENCE OF AGING POPULATION ABOVE 65 YEARS 2005 & 2015 (%)
FIGURE 34 GERMANY STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 35 SPAIN STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 36 ITALY STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 37 ROE STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 38 GROWING PREVALENCE OF THE CHRONIC DISORDERS IN ASIAN COUNTRIES BY GENDER 2015
FIGURE 39 ASIA-PACIFIC MARKET SHARE BY REGION 206 & 2025 (%)
FIGURE 40 INDIA STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 41 CHINA STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 42 JAPAN STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 43 THE GROWING NUMBER OF BIOTECHNOLOGY FIRMS IN KOREA
FIGURE 44 SOUTH KOREA STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 45 ROAPAC STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 46 REST OF THE WORLD STEM CELL ASSAY MARKET BY COUNTRY 2016 & 2024 (%)
FIGURE 47 LATIN AMERICA STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 48 MENA STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 49 AFRICA STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
